Robert Carson - Waters Senior Vice President - Corporate Development
| WAT Stock | USD 388.15 9.99 2.64% |
President
Mr. Robert G. Carson, serves as Senior Vice President, Corporationrationrate Development in February 2018. Prior to joining Waters Corporationrationration, he held several positions during his 16 years at Medtronic plc, including Vice President and General Manager, Pacemaker Business from January 2017 to January 2018. In addition, Mr. Carson spent nearly 12 years in Medtronics spinal implants and biologics business, serving as Vice President and General Manager from July 2016 to January 2017, Vice President of Global Marketing Strategy from April 2015 to July 2016 and Vice President Therapy Segment Leader from October 2012 to April 2015 since 2018.
| Age | 46 |
| Tenure | 6 years |
| Address | 34 Maple Street, Milford, MA, United States, 01757 |
| Phone | 508 478 2000 |
| Web | https://www.waters.com |
Waters Management Efficiency
The company has Return on Asset of 0.1133 % which means that on every $100 spent on assets, it made $0.1133 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.4964 %, implying that it generated $0.4964 on every 100 dollars invested. Waters' management efficiency ratios could be used to measure how well Waters manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.23 in 2024, whereas Return On Tangible Assets are likely to drop 0.14 in 2024. At this time, Waters' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 89.2 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 719.7 M in 2024.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Richard III | IQVIA Holdings | 61 | |
| Angela Lalor | Danaher | 59 | |
| William King | Danaher | 53 | |
| Riaz MBA | Sotera Health Co | 54 | |
| Daniel Raskas | Danaher | 54 | |
| Charles Dadswell | Illumina | 65 | |
| Michael McDonnell | IQVIA Holdings | 55 | |
| Stephen Williamson | Thermo Fisher Scientific | 57 | |
| Simon Holmes | ICON PLC | 57 | |
| Rob Kotchie | IQVIA Holdings | N/A | |
| Brian Mi | IQVIA Holdings | 58 | |
| Diarmaid Cunningham | ICON PLC | 49 | |
| David Smith | Charles River Laboratories | 58 | |
| William Barbo | Charles River Laboratories | 63 | |
| Nilton Paletta | IQVIA Holdings | N/A | |
| Michael Lane | IDEXX Laboratories | 55 | |
| Mark Stevenson | Thermo Fisher Scientific | 57 | |
| Wendy Stewart | IQVIA Holdings | N/A | |
| Michel Lagarde | Thermo Fisher Scientific | 49 | |
| Michael Rutz | Sotera Health Co | 53 | |
| Birgit Girshick | Charles River Laboratories | 54 | |
Management Performance
Waters Leadership Team
Elected by the shareholders, the Waters' board of directors comprises two types of representatives: Waters inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Waters. The board's role is to monitor Waters' management team and ensure that shareholders' interests are well served. Waters' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Waters' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Lynch, Vice President Investor Relations | ||
| Gary Hendrickson, Independent Director | ||
| Edward Conard, Independent Director | ||
| Linda Baddour, Independent Director | ||
| JoAnn Reed, Advisor to CEO, Director and Member of Audit Committee | ||
| Flemming Ornskov, Independent Chairman of the Board | ||
| Christopher Kuebler, Independent Director | ||
| Christos Ross, Senior Operations | ||
| Michael Berendt, Independent Director | ||
| Kevin Kempskie, Director PR | ||
| Sherry Buck, Chief Financial Officer, Senior Vice President | ||
| Michael Silveira, Chief Financial Officer, Principal Accounting Officer | ||
| Belinda Hyde, Senior Vice President of Global Human Resources | ||
| Daniel Rush, Senior Transformation | ||
| Pearl Huang, Independent Director | ||
| Robert III, Senior Division | ||
| Patrick Conway, Interim Resources | ||
| Laurie Glimcher, Independent Director | ||
| Amol Chaubal, Chief Financial Officer, Senior Vice President | ||
| Christopher OConnell, Chairman of the Board, President, Chief Executive Officer | ||
| Jiang Wei, Director | ||
| Thomas Salice, Lead Independent Director | ||
| Udit Batra, President, Chief Executive Officer, Director | ||
| Michael Harrington, Senior Vice President - Global Markets | ||
| Ian King, Senior Vice President - Instrument Technology | ||
| Jonathan Pratt, Senior Vice President and President of TA Instruments | ||
| Caspar Tudor, Director Relations | ||
| Keeley JD, General VP | ||
| Robert Carson, Senior Vice President - Corporate Development | ||
| Dan Welch, Senior Vice President of Global Operations | ||
| Jianqing Bennett, VP Division | ||
| Kristen Garvey, Vice Communications | ||
| Elizabeth Rae, Senior Vice President - Global Human Resources | ||
| John Ballbach, Independent Director | ||
| Keeley Aleman, Senior Vice President General Counsel and Corporate Secretary |
Waters Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Waters a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.5 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.29 % | ||||
| Current Valuation | 24.62 B | ||||
| Shares Outstanding | 59.38 M | ||||
| Shares Owned By Institutions | 96.80 % | ||||
| Number Of Shares Shorted | 2.08 M | ||||
| Price To Earning | 40.43 X | ||||
| Price To Book | 14.38 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Waters Stock Analysis
When running Waters' price analysis, check to measure Waters' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Waters is operating at the current time. Most of Waters' value examination focuses on studying past and present price action to predict the probability of Waters' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Waters' price. Additionally, you may evaluate how the addition of Waters to your portfolios can decrease your overall portfolio volatility.